drugset / Trial / NCT01946243

The Feasibility of Florbetapir Quantitation

NCT01946243

Phase 4 Completed 96 enrolled Avid Radiopharmaceuticals
NaSingle-groupSingle-blindDiagnostic

Summary

The overall objective of the study is to assess the feasibility of implementing a quantitative process of florbetapir F 18 scan interpretation. The hypothesis is that the use of quantitative analysis will increase the accuracy of florbetapir F 18 scan interpretation.

Timeline

Start
2013-08
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Background florbetapir F 18 Diagnostic / imaging agent

Indications